[HTML][HTML] North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension

JR Boike, BG Thornburg, SK Asrani, MB Fallon… - Clinical …, 2022 - Elsevier
Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic
hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and …

An update on the management of Budd–Chiari syndrome

A Sharma, SN Keshava, A Eapen, E Elias… - Digestive diseases and …, 2021 - Springer
Budd–Chiari syndrome (BCS) is an uncommon condition, caused by obstruction to hepatic
venous outflow. It is largely underdiagnosed, and a high index of suspicion is required for …

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension

D Tripathi, AJ Stanley, PC Hayes, S Travis… - Gut, 2020 - gut.bmj.com
These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the
management of portal hypertension have been commissioned by the Clinical Services and …

Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)

A Shukla, A Shreshtha, A Mukund, C Bihari… - Hepatology …, 2021 - Springer
Budd Chiari syndrome (BCS) is a diverse disease with regard to the site of obstruction, the
predisposing thrombophilic disorders and clinical presentation across the Asia-Pacific …

Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis

G Han, X Qi, C He, Z Yin, J Wang, J Xia, Z Yang… - Journal of …, 2011 - Elsevier
BACKGROUND & AIMS: Data on the management of portal vein thrombosis (PVT) in
patients with decompensated cirrhosis are extremely limited, particularly in the cases of the …

Budd–Chiari syndrome/hepatic venous outflow tract obstruction

DC Valla - Hepatology international, 2018 - Springer
Abstract Background Budd–Chiari syndrome (BCS) is a rare disease characterized by
hepatic venous outflow tract obstruction (HVOTO). Methods Recent literature has been …

[HTML][HTML] State of the art, current perspectives, and controversies of Budd-Chiari syndrome: a review

P Gavriilidis, G Marangoni, J Ahmad… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Background Budd-Chiari syndrome (BCS) is an eponym that includes a group of conditions
characterized by partial or complete hepatic venous tract outflow obstruction, and the site of …

Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension: review and update of the literature

ML Hung, EW Lee - Clinics in liver disease, 2019 - liver.theclinics.com
Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal
Hypertension - Clinics in Liver Disease Skip to Main Content Advertisement Clinics in Liver …

a multidisciplinary approach to the diagnosis and management of Budd‐Chiari syndrome

F Khan, MJ Armstrong, H Mehrzad… - Alimentary …, 2019 - Wiley Online Library
Summary Background Budd‐Chiari syndrome (BCS) is a rare but fatal disease caused by
obstruction in the hepatic venous outflow tract. Aim To provide an update of the …

Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis

G Mukhiya, X Zhou, X Han, D Jiao, G Pokhrel, Y Li… - Scientific Reports, 2022 - nature.com
This study was performed to evaluate the outcome of endovascular intervention therapy for
Budd-Chiari syndrome (BCS) and compare recanalization, transjugular intrahepatic …